腹腔镜联合GnRHa治疗卵巢型子宫内膜异位症临床疗效观察及复发相关因素分析
[Abstract]:Objective: there are many controversies in the combination of surgery and drug therapy for endometriosis, and the factors affecting the recurrence of endometriosis are also controversial. In this study, postoperative pain relief, pregnancy, To analyze the curative effect of laparoscopic conservative surgery combined with Gn RHa (Gonadotropin-releasing hormone agonists, gonadotropin releasing hormone agonist. To study the factors related to recurrence of endometrial cysts after laparoscopic conservative surgery. Methods: conservative laparoscopic surgery was performed at Beijing Obstetral Gynecology Hospital from July 2012 to July 2014. According to the standard staging of the American Fertility Association (r-AFS), stage III and above were all performed during the operation. And 360 women with endometriosis were confirmed by pathology. The follow-up period was 2-3 years. 317 cases were followed up and 43 cases were lost. The rate of missing visit was 11.94%. The basic clinical data and pregnancy after operation were collected and analyzed. According to whether combined use of Gn RHa before and after operation and time group, the curative effect of different treatment methods was analyzed through postoperative pain relief, recurrence rate and pregnancy rate. The basic data of postoperative recurrence and non-recurrence were statistically analyzed to study the related factors of postoperative recurrence of endometriosis cysts. Results: the preoperative CA125 of 302 patients was P 25 18.35 U / ml P 75 52.5 U / ml 路ml. There was no significant difference in the location of cysts in asymptomatic, pain and infertility patients before operation (P0.05). There was no significant difference in pain relief in postoperative 2-3 years, cumulative recurrence rate and natural pregnancy rate in postoperative 2-3 years in simple operation group, postoperative injection Gn RHa1-3 needle group and postoperative Gn RHa4-6 needle group (P0.05). In the simple operation group, Gn RHa group was used before operation, Gn RHa group was used after operation, Gn RHa group was used before and after operation, and the pain relief was observed in the group of intrauterine sustained release of levonorgestrel (LNG-IUS) for 2-3 years after operation. There was no significant difference in cumulative recurrence rate and natural pregnancy rate between 2-3 years after operation (P0.05). Logistic regression analysis showed that preoperative CA125 index (P0.05OR value 1, regression coefficient 0) might be the risk factor of recurrence. The delayed age of menarche (P 0.05 OR 1, regression coefficient 0) may be the protective factor of recurrence. The average age of spontaneous pregnancy group was 29.32 卤3.75 years old, and that of infertile group was 31.86 卤4.40 years old. There was statistical difference between the two groups (P0.05). There were 11 postmenopausal patients (3.47%) with an average age of 48.18 years. 27 cases (8.52%) had irregular menstruation, 38 cases (11.99%) decreased menstrual volume, 18 cases shortened menstrual period (5.68%), 3 cases prolonged menstrual period (0.95%). Conclusion: operation may result in ovarian function injury and irregular menstruation, postoperative combined use of Gn RHa can relieve pain, reduce recurrence and increase pregnancy rate in 2-3 years after operation. The effect of the same operation combined with Gn RHa,LNG-IUS was not satisfactory compared with that of the simple operation group in 2-3 years after operation. The recurrence rate of 2 to 3 years after follow-up showed that preoperative CA125 might be a risk factor for recurrence of ovarian endometriosis and delayed menarche might be a protective factor for recurrence. The natural pregnancy rate was 69.86, and the average age of the natural pregnant group was significantly different from that of the infertile group. Therefore, it was suggested that the endometriosis patients with fertility requirement should get pregnant as soon as possible after operation.
【学位授予单位】:首都医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R711.71
【相似文献】
相关期刊论文 前10条
1 袁明;汪雯雯;高玲;栗妍;李天;王世宣;;长效GnRHa预防卵巢子宫内膜异位症术后复发的疗效[J];中国妇幼保健;2013年30期
2 刘雅琴;促性腺激素释放激素增效剂(GnRHa)疗法副作用的预防措施[J];国外医学.妇产科学分册;1994年02期
3 姜海英;韩萍;;促性腺激素释放激素激动剂(GnRHa)与卵巢保护[J];中国妇幼保健;2010年09期
4 梁光华;叶连红;;腹腔镜手术联合GnRHa治疗卵巢子宫内膜异位囊肿40例[J];陕西医学杂志;2010年08期
5 龚绍琼;;GnRHa长方案中促性腺激素用量对体外受精胚胎移植结局的影响[J];实用医学杂志;2012年15期
6 白晓红,糜若然;GnRHa对体外培养的卵巢黄素化颗粒细胞分泌功能的影响[J];天津医药;2005年10期
7 田莉;未使用GnRHa降调节的有卵巢功能的妇女接受冻融胚胎移植周期子宫内膜准备的弹性方案[J];国外医学(计划生育分册);2000年03期
8 赵岫;张琴;高晓杰;;基因重组人生长激素对GnRHa治疗中生长减速的特发性中枢性性早熟患儿身高的影响[J];山东医药;2011年44期
9 蔡正维;刘孝桥;黄懿娟;王敏;熊安秀;;GnRHa激发试验与GnRH激发试验对性早熟诊断价值的比较研究[J];临床和实验医学杂志;2012年23期
10 程丹;杨菁;熊承良;徐望明;李洁;邹宇洁;郭跃;彭祥炽;;黄体中期GnRHa长方案中Gn刺激时间与IVF结局的关系[J];华中科技大学学报(医学版);2013年03期
相关会议论文 前7条
1 林琼燕;王沂峰;生秀杰;翁慧男;;GnRHa对裸鼠卵巢癌移植瘤模型的化疗效果影响及卵巢功能保护的实验研究[A];中华医学会第十次全国妇产科学术会议妇科肿瘤会场(妇科肿瘤学组、妇科病理学组)论文汇编[C];2012年
2 魏锁成;邹文辉;张勇;宋洋铭;巩转娣;张峰;李玉孔;;GnRHa主动免疫对绵羊FSH与LH分泌及阴道电阻的作用研究[A];中国畜牧兽医学会——第三届中国兽医临床大会论文集[C];2012年
3 严天连;虞朝辉;厉有名;;幽门螺杆菌复发率与国家人类发展指数呈显著负相关[A];2013第六届浙江省消化病学术大会论文汇编[C];2013年
4 郭田荣;郭志华;薛殿凯;;父母接受护理健康教育对首发精神分裂症复发率的影响[A];河南省精神科康复护理培训班及学术研讨会论文集[C];2009年
5 李平;李世根;刘永刚;张国祥;谢少玲;;白芍总贰对慢性荨麻疹患者辅助T细胞和复发率的影响研究[A];2014年广东省药师周大会论文集[C];2014年
6 孙晓燕;柴忆欢;;大于10岁儿童及青少年急性淋巴细胞白血病临床及预后分析[A];中华医学会第十七次全国儿科学术大会论文汇编(上册)[C];2012年
7 史正新;;中西医结合治疗肺结核60例疗效分析[A];第五次全国中西医结合呼吸病学术交流大会论文汇编[C];2000年
相关重要报纸文章 前1条
1 健康时报实习记者 王良娜;北京卒中复发率近三成[N];健康时报;2009年
相关博士学位论文 前2条
1 夏元;姜黄素多靶点抑制单纯疱疹病毒性角膜炎复发的作用研究[D];南京医科大学;2017年
2 徐靖雯;益气解毒法干预UC复发率的系统评价及其维持肠上皮细胞自噬的机制研究[D];广州中医药大学;2017年
相关硕士学位论文 前10条
1 李宛真;腹腔镜联合GnRHa治疗卵巢型子宫内膜异位症临床疗效观察及复发相关因素分析[D];首都医科大学;2017年
2 王盈;GnRHa对化疗致卵巢损伤保护机制的探讨[D];河南科技大学;2015年
3 林琼燕;GnRHa对裸鼠卵巢癌移植瘤模型的化疗效果影响及卵巢功能保护的实验研究[D];广州医学院;2010年
4 王喜平;在GnRHa激发试验中儿童尿促性腺激素(免疫化学发光法)动态观察[D];苏州大学;2010年
5 李欢;促性腺激素释放激素激动剂(GnRHa)对化疗大鼠卵巢损伤防护作用的研究[D];第四军医大学;2008年
6 王婧;米非司酮与GnRHa预防内异症术后复发的疗效观察[D];新疆医科大学;2009年
7 陈荔;腹腔镜术后辅助GnRHa治疗子宫肌瘤的临床疗效观察[D];新疆医科大学;2013年
8 殷美静;GnRHa联合腹腔镜手术治疗大孕周子宫肌瘤的探讨[D];青岛大学;2017年
9 韦敏;GnRHa主动免疫绵羊对GnRHR表达与分布的作用研究[D];西北民族大学;2012年
10 臧艳秋;胃肠道小间质瘤的诊断与治疗研究(附61例病例分析)[D];河北医科大学;2015年
,本文编号:2367625
本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/2367625.html